Background: Psoriasis is a chronic inflammatory disorder, characterized by increased keratinocyte proliferation due to abnormal differentiation of basal keratinocytes. The etiology of the disease is unclear, and according to the survey results, it is hypothesized that a combination of genetic and environmental factors prompts an abnormal immune response in patients with psoriasis. CD4+ Th cells play a multifaceted role in both immune defense and pathogenesis of certain diseases such as psoriasis. Nonetheless, the exact contribution of different subpopulations of Th cells in psoriasis is still not clear. oBjective: The aim of present study was to determine the mRNA expression level of RORC as potential inducer of Th17 cell differentiation and expression pattern of Th17-signature cytokines (IL-17A and IL-22). Methods: Twenty patients with psoriasis and twenty-one healthy subjects were included in the study. Peripheral blood mononuclear cells (PBMCs) were separated and expression of three genes were determined by quantitative real-time reverse transcriptase PCR (qRT-PCR). Plasma levels of IL-17 and IL-22 were also evaluated by ELISA. results: RORC, IL-17A and IL-22 gene expression was significantly higher in patients with psoriasis compared with healthy controls (P<0.05). In addition, a marked increase in plasma IL-17A and IL-22 levels was observed in patient group compared to controls (P<0.001). study liMitations: small number of patients. conclusion: These data suggest that Th17 response may contribute to the pathogenesis of psoriasis.
INTRODUCTION
Psoriasis is a chronic inflammatory disorder, characterized by increased keratinocyte proliferation due to abnormal differentiation of basal keratinocytes. The etiology of the disease is unclear, and according to the survey results, it is hypothesized that a combination of genetic and environmental factors prompts an abnormal immune response in patients with psoriasis. 
Th17-cells are special subpopulations of CD4+ T-cells that pro-
duce proinflammatory cytokines such as IL-17A and IL-22 and express lineage-specific transcription factor RORC. These cells play a key role in host defense against extracellular pathogens. However, under certain circumstances, they have also been implicated in the pathogenesis of a variety of autoimmune and inflammatory diseases including psoriasis.
2,3
Augmented or unbalanced activation of T cells with shift toward Th17 responses, not only disturb appropriate immune responses but also provide suitable conditions for the development of psoriasis. However, there is no consensus in the literature on this issue. [4] [5] [6] Hence, identification of molecular mechanisms that control the specification and differentiation of CD4+ T cells into Th17 effector cells in diseased subjects will substantially improve our insight into disease pathogenesis. Therefore, the goal of this research was to
(1) determine RORC, IL-17A, and IL-22 mRNA expression patterns in PBMCs of patients with psoriasis and healthy control subjects, (2) analyze the correlation between RORC and IL-17A/IL-22 to understand the potential role of this transcription factor in signaling for the differentiation of Th17 lymphocytes, and (3) to assess whether there is a difference in cytokine levels (IL-17A and IL-22) between healthy subjects and patients with psoriasis. (denaturation) and final step of 20s at 62ºC for RORC, 45s at 57ºC for IL-17A, 45s at 60ºC for IL-22, and 20s at 63ºC for β-actin.
METHODS

Sampling
PCR primers pairs were designed by using OLIGO software (National Biosciences) and purchased from Gene fanavaran (Tehran, Iran). The specific sequences of primers used in this study are shown in table 1.
Relative quantities for all samples were normalized to their corresponding β-actin levels. The cycle threshold(Ct) method was used to determine the amplification of the genes relative to β-actin as endogenous control. The Ct levels are inversely proportional to the abundance of a target mRNA in the samples. Therefore, lower Ct levels reveal elevated amounts of mRNA, whereas higher Ct levels indicate decreased amounts of mRNA.
Cytokines assay
The levels of IL-17A and IL-22 were determined using an enzyme-linked immunosorbent assay method according to the manufacturer's instructions (Bender Med Systems, San Diego, California, USA). 
Statistical Analysis
Alterations in plasma inflammatory cytokines of patients with psoriasis
The cytokines examined in the present study were detected in plasma samples of all patients and controls. Both IL-17A (P = 0.043) and IL-22 (P = 0.001) concentrations were significantly higher in psoriatic patients than in healthy controls (Figure 4 ). cell-mediated disease, however, it is now obvious that a specific IL-17 and IL-22-producing CD4+ T cell subset contribute to the pathogenesis of this important skin disease. The significance of Th17 cells in psoriasis comes from clinical and experimental studies. 2, 10 Therefore, the first step of this survey was conducted to compare the expression pattern of Th17-specific transcription factor RORC in PBMCs of patients with psoriasis and control subjects.
Correlation analysis
Our results indicated a considerable increase in RORC mRNA level in PBMCs of patients compared to healthy controls and are consistent with earlier studies showing elevated expression of RORC transcripts in peripheral blood of patients with psoriatic arthritis.
11
Increased transcript level of RORC was also encountered in skin lesions of psoriatic patients when compared with uninvolved skin and healthy control skin. 12 Therefore, gene expression changes of RORC mRNA may be implicated in the pathogenesis of psoriasis.
In another part of this study, the expression levels of IL-17A
and IL-22 were analyzed. Moreover, the plasma levels of these cytokines were measured by ELISA. Our attention was focused on these cytokines because of their importance as a major cytokine product of Th17 cells. Furthermore, altered production of these cytokines are thought to play a critical role in pathogenic host immune responses.
The potential role of Th17 lymphocytes in patients with psoriasis
FIgure 1: mRNA expression levels for RORC in patients and control subjects. β-acttin was used as the internal control. Please note that a higher DCt value corresponds to a comparably lower expression level FIgure 4: Plasma cytokine levels of psoriasis patients and controls FIgure 2: mRNA expression levels for IL-17A in patients and control subjects. β-action was used as the internal control. Please note that a higher DCt value corresponds to a comparably lower expression level between IL-17 and IL-22 mRNA and disease activity in the skin lesions of patients with psoriasis. 13 In another study, Takahashi et al.
indicated a positive correlation between the serum IL-17 levels and PASI. 15 In separate studies, a significant positive correlation was also observed between the serum IL-22 concentration and PASI or disease severity. [17] [18] [19] These results are contrary to the findings of de Oliveira et al.
who can not show any correlation between serum levels of IL-17A
and IL-22 and disease activity. 20 These controversies may be related to different factors such as heterogeneity of the inclusion criteria, study population, different types of psoriasis, and different mean value of PASI in evaluated patients. 
